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ABSTRACT 
Objective: This study aimed to review the literature 
about blood concentrations of selenium associated with ges-
tational age, feeding, supplementation and related clinical 
features in preterm infants. 
Data sources: Systematic review in the following da-
tabases: MEDLINE, PubMed, Google academics, SciELO.
org, ScienceDirect (Elsevier) and CINAHL-Plus with Full 
Text (EBSCO). Articles published up to January 2013 with 
the keywords “selenium deficiency”, “selenium supple-
mentation”, “neonates”, “infants”, “newborn” and “preterm 
infants” were selected. 
Data synthesis: The studies reported that low blood 
selenium levels are associated with increased risk of respi-
ratory diseases. Preterm infants, especially with low birth 
weight, presented lower selenium levels. Selenium deficiency 
has also been associated with the use of oral infant formula, 
enteral and parenteral nutrition (with or without selenium 
addition). The optimal dose and length of selenium supple-
mentation is not well-established, since they are based only 
on age group and selenium ingestion by breastfed children. 
Furthermore, the clinical status of the infant affected by con-
ditions that may increase oxidative stress, and consequently, 
selenium requirements is not taken into account. 
Conclusions: Prematurity and low birth weight can 
contribute to low blood selenium in premature infants. 
Selenium supplementation seems to minimize or prevent 
clinical complications caused by prematurity.
Key-words: review; selenium; supplementation; infant, 
newborn; infant, premature. 
RESUMO
Objetivo: Revisar os trabalhos que analisaram as concentra-
ções sanguíneas de selênio associadas à idade gestacional, à ali-
mentação, à suplementação e ao quadro clínico de prematuros. 
Fontes de dados: Revisão sistemática da literatura por 
meio de buscas eletrônicas nas seguintes bases de dados: 
MEDLINE PubMed, Google acadêmico, SciELO.org, Scien-
ceDirect (Elsevier) e CINAHL-Plus with Full Text (EBSCO). 
Buscaram-se trabalhos publicados até janeiro de 2013 com as 
seguintes palavras-chave: “selenium deficiency”, “selenium supple-
mentation”, “neonates”, “infants”, “newborn” e “preterm infants”. 
Síntese dos dados: Os estudos relataram que os baixos 
níveis selênio associam-se ao risco aumentado para doenças 
respiratórias. Os prematuros, principalmente com baixo 
peso ao nascer, apresentam os menores níveis de selênio. 
A deficiência do mineral tem sido associada ao uso de fórmula 
infantil oral, nutrição enteral e parenteral (com e sem adição 
de selênio). A dosagem e o tempo ideal para a suplementação 
de selênio ainda não estão bem estabelecidos, visto que se 
baseiam apenas na faixa etária e na ingestão do mineral por 
crianças amamentadas no peito. Além disso, não se considera 
o quadro clínico do recém-nascido, que pode ser acometido 
de doenças que aumentam o estresse oxidativo e, consequen-
temente, elevam as necessidades de selênio. 
Conclusões: A prematuridade e o baixo peso ao nascer 
podem contribuir para reduzir as concentrações sanguíneas de 
selênio em prematuros. A suplementação parece minimizar ou 
prevenir as complicações clínicas causadas pela prematuridade. 
Palavras-chave: revisão; selênio; suplementação; 
recém-nascido; prematuro.
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RESUMEN
Objetivo: Revisar los trabajos que analizaron las con-
centraciones sanguíneas de selenio asociadas con la edad 
gestacional, alimentación, suplementación y cuadro clínico 
de prematuros.
Fuentes de datos: Revisión sistemática de la literatura 
mediante búsquedas electrónicas en las bases de datos a 
continuación: Medline Pubmed, Google académico, SciELO.
org, SienceDirect (Elsevier) y CINAHL with Full Text 
(EBSCO). La búsqueda se realizó con trabajos publicados 
hasta enero de 2013 con las palabras clave a continuación: 
selenium deficiency, selenium supplementation, neonates, infants, 
newborn and preterm infants. 
Síntesis de los datos: Los estudios relataron que los bajos 
índices de selenio están asociados al riesgo aumentado para 
enfermedades respiratorias. Los prematuros, principalmente 
con bajo peso al nacer, presentan los menores niveles de selenio. 
La deficiencia de selenio viene siendo asociada al uso de fórmula 
infantil oral, nutrición enteral y parenteral (con y sin adición 
de selenio). La dosis y el tiempo ideal para la suplementación de 
selenio todavía no están bien establecidos, puesto que se basan 
solamente en la franja de edad y en la ingestión de selenio 
de niños amamantados al pecho. Además, no se considera el 
estado clínico del recién nacido, que puede ser acometido por 
enfermedades que aumentan el estrés oxidativo y, por consi-
guiente, elevan las necesidades de selenio. 
Conclusiones: La prematuridad y el bajo peso al nacer pue-
den contribuir para reducir las concentraciones sanguíneas de 
selenio en prematuros. La suplementación parece reducir o pre-
venir las complicaciones clínicas causadas por la prematuridad.
Palabras clave: revisión sistemática; deficiencia de 
selenio; suplementación de selenio; recién nacido; prematuro.
Introduction
Selenium is a trace element considered essential due to 
its participation in major metabolic functions(1,2), immune 
system, thyroid hormone metabolism(1,2), male infertility, 
neoplasms and cardiovascular disease(2). It also has antioxi-
dant properties(1,3).
Selenium is an active-site component of glutathione 
peroxidase (GPx)(4). This enzyme contains four atoms of se-
lenium and is responsible for nearly 30% of plasma selenium 
levels(1,5). GPx has antioxidant function(3), thereby protecting 
body cells from oxidation and reducing toxic substances 
caused by oxidative stress(6). 
In 1979, it was discovered that selenium supplementation 
could prevent the appearance of Keshan disease, a cardiomy-
opathy affecting children living in regions of selenium-defi-
cient soil(7). In the pediatric population, selenium deficiency 
is most commonly found in preterm infants, associated with 
gestational age, feeding after birth and clinical status(8-10).
According to the National Health and Medical Research 
Council (NH&MRC, 2006)(11), the daily recommended oral 
dose of selenium is 12–15µg. For enteral nutrition, the rec-
ommended dose is 1.3–3.0µg/kg/day. For parenteral nutri-
tion, the European Society for Paediatric Gastroenterology, 
Hepatology and Nutrition (ESPGHAN, 2005)(12) has rec-
ommended the administration of 2–3µg/kg/day. Currently, 
the American Society for Parenteral and Enteral Nutrition 
(ASPEN, 2012)(13) suggested an improvement of recommend-
ed intake of selenium from 20–60 µg/day to 60–100µg/day 
for adults. With respect to pediatric patients, including 
neonates, the recommended dose remained 2µg/kg/day(13-16).
The addition of selenium to oral, enteral and parenteral 
infant formulas is not a routine practice in all countries and 
health care services. In Brazil, selenium is not routinely 
added to parenteral nutrition, despite studies reporting 
that selenium supplementation may prevent or correct a 
deficiency in this mineral(17-19). 
This study aimed to review the literature about blood 
selenium concentrations in preterm infants associated with 
gestational age, feeding, supplementation and related clini-
cal features. 
Method
A systematic review was conducted by electronic search. 
Medline Pubmed, Google Scholar and Capes Platform da-
tabases were used for a refined search in the following data-
bases: SciELO.org, ScienceDirect (Elsevier) and CINAHL-
Plus with Full Text (EBSCO). Searches were made of studies 
published up to January, 2013 with the following keywords: 
selenium deficiency, selenium supplementation, neonates, newborn, 
preterm infants. No limitations were applied regarding date 
of publication and language. The exclusion criteria were as 
follows: review papers, animal research, studies with dead 
children and studies with inadequate age group. For data 
collection, Boolean operators that broadened or restricted the 
number of articles identified by the search system were used.
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Table 1 - Type of study, location, case study, feeding form and conclusion in selected studies 
Author/year Type of study Country Population Feeding
Amin et al, 
1980(28)
Study 1:  
Cross- 
sectional
Study 2: 
Longitudinal
USA Study 1: 68 preterm infants  
(GA 28–36wks.), 18 term infants,  
50 normal children. 
Study 2: 8 preterm infants with severe 
respiratory insufficiency. Assessment 
until the 6th wk of age. 
PN and  F
Lockitch et al, 
1989(21)
Prospective 
observational 
longitudinal
Canada Baseline: 56 healthy term newborns 
and 39 LBW infants with a mean (SD) 
BW of 1940±257g and 35 VLBW 
infants of 1064±264g  with <37wks. of 
gestation. Assessment until the 7th wk 
of life in 16 preterm infants. 
PN (without Se) with or 
without oral intake. 
Huston et al, 
1991(47)
Prospective 
Randomized 
Clinical Trial
USA 20 preterm infants (BW<1000 g). 
 The mean (SD) GA in G1=26.7±1.5 
and G2=26.5±1.2 wks. Assessment 
until the 60th day. 
PN and EN. G1 (n = 10; 
1.34µg/kg/day of selenious 
acid) and G2 (without Se).
Smith et al, 
1991(29)
Prospective
Clinical Trial
USA 46 preterm infants (BW<1700 g). The 
mean GA was 29.3 weeks. Assessment 
until the 3th wk of life.
BF (n=21; 24ng Se/mL),  
F (n=13; 7.8 ng Se/mL), and 
F (n=12; 34.8 ng Se/mL).
Mask et al, 
1993(27)
Cross-
sectional
USA 13 preterm newborns (Mean (SD) 
BW and GA was 1869±449g and 
33.5±1.8wks.), 15 term newborns and 
their mothers and 15 women who were 
not pregnant.
(Not differentiated)
Darlow et al, 
1995(32)
Prospective 
observational 
longitudinal
New Zealand 79 preterm newborns with a mean (SD) GA 
of 28.3±2.5wks. And BW of 1164±254g. 
Assessment until the 28th day of life.
PN (without Se), EN and 
BF or F. 
Daniels et al, 
1996(18)
Prospective 
Randomized 
Clinical Trial 
Australia Preterm newborns (G1: 19 and G2: 19) 
healthy term newborns (RG=32). The 
mean (SD) BW and GA were 1171±38g 
and 29±0.3wks. Assessment until the 
6th wk of life.
G1:PN (without Se),  
G2:PN (3µg/kg/day of 
selenious acid) and RG  
(F and BF).  
Bogye et al, 
1998(51)
Randomized 
Clinical Trial
Hungary 36 preterm newborns with VLBW. 
BW of 975±122g and GA 27±1wk. 
Supplementation for 14 days.
G1 (n=18): (nasogastric EN 
by drip) with 4.8mg yeast  
(5µg of Se) G2 (n=18): not 
supplied
Bogye et al, 
1998(38)
Randomized 
Clinical Trial 
Hungary 28 preterm newborns with birth weight 
and GA of 962±129g and 27±1wk. 
Supplementation for 14 days.
G1 (n=14): (nasograstric 
EN by drip) with 4.8mg of 
yeast (5µg of Se).  
G2 (n=14): not supplied
Merz et al, 
1998(40)
Prospective Germany 34 VLBW infants with GA and BW 
28.6±2.5wks. and 1075±249g respectively.  
Assessment until 4th wk of life.
Mainly PN and were not 
specifically supplied with 
Se.
Klinger et al, 
1999(39)
Cross-
sectional
Israel 29 VLBW infants with mean (SD) age 
and weight 26±1.7wks and 809±129g Se: 2µg/kg/d selenious acid.
Darlow et al, 
2000(24)
Double-blind 
placebo-
controlled 
randomized
Trial
New Zealand 534 infants with BW<1500g
Assessment until 36wks of life.
PN: 7µg/kg/d and  
F: 5µg/kg/day sodium 
selenite.
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Table 1 - Continuation
One hundred and eighty-nine (189) articles were found. 
Of these, 18 were selected and 171 excluded (63 repeated 
studies, 50 animal studies, 14 review articles, 27 with inad-
equate age group, 11 did not address the topic, 6 reported 
dead children). 
Thus, based on titles and abstracts, 18 studies were chosen 
for this systematic review. After the selection of studies, level 
of evidence and grades of recommendation were classified 
according to Brazilian Medical Association(20).
Results
Eighteen articles analyzing selenium concentrations in 
preterm infants were selected. Table 1 shows study design, 
population characteristics and forms of feeding. According 
to the criteria of the Brazilian Medical Association(20), studies 
were classified as A or B. In table 2, a relationship between 
selenium status and age of the child is observed. 
Concerning birth weight, Makhoul et al(8) observed that 
the lower the weight, the lower the selenium concentration 
(r=0.237; p=0.002). Lockitch et al(21) found a significant 
correlation between BW and plasma Se (r=0.47; p<0.001). 
Plasma GPx levels were more highly correlated with birth weight 
(r=0.64; p<0.001). In addition, studies have related altera-
tions in selenium concentration and clinical status (Table 3).
Table 4 shows studies correlating the amount of selenium 
provided by feeding routes used with selenium concentra-
tions observed in studies of children.
Discussion
It is known that the pediatric population, particularly pre-
mature infants(8-10), is vulnerable to low Se concentrations due 
to nutritional changes(22), possible clinical complications(10,23) 
and low selenium liver stores(8,9,24-26). This occurs because of 
immature chorionic villi that acts in the transport of this min-
eral and also due to inadequate intestinal absorption(8,9,25,26).
During pregnancy, maternal blood selenium levels 
decrease, reflecting a greater amount of selenium trans-
ported to the fetus in the 3rd trimester of pregnancy. 
Mask et al(27), Amin et al(28) and Smith et al(29) suggest that low 
selenium values found in preterm infants must be associated 
Author/year Type of study Country Population Feeding
Winterbourn 
et al, 2000(48) 
Randomized 
controlled 
Trial
New Zealand 173 newborns with weight <1500g. 
Assessment until 36wks of life.
PN: 7µg/kg/d and  
F: 5µg/kg/day sodium 
selenite.
Sievers et al, 
2001(45)
Prospective 
observational 
longitudinal
Germany 16 preterm newborns (GA 25–32wk and 
BW 595–1495g), 14 term newborns 
with F and 17 term newborns with BF. 
Assessment until 1st year of life.
BF, F and complementary 
feeding. 
Makhoul et al, 
2004(8)
Cross-
sectional
Israel 165 preterm newborns and term 
newborns (24–42wks.) and their 
mothers. 
 (Not differentiated)
Mentro et al, 
2004(9)
Prospective 
observational 
longitudinal
14 Caucasians, 
3 Hispanics 
and 1 Asian-
American
18 preterm newborns with BW of  
1013g (650–1370g) and risk of BPD. 
Mean GA was 27 weeks. Assessment 
until 4th week of life.
BF, PN, EN and F. Mean 
ingestion of Se in the 1st 
wk was 0.82µg/kg/day and 
1.7µg/kg/day in the 4th wk.
Galinier et al, 
2005(30)
Cross-
sectional
France 248 preterm newborns and 262 
term newborns. The mean GA and 
BW (SD) for preterm newborns was 
32.4±2.52wks. and 1845±489g. 
(Not differentiated)
Nassi et al, 
2009(10)
Prospective 
observational 
longitudinal
Italy 30 preterm infants with mean (SD) 
 BW and GA of 1605±122 g and  
34.5±0.5 wk. The control group 
included 30 term infants. Assessment 
until the 100th day of life.
BF
BF: breastfed; BPD: bronchopulmonary dysplasia; BW: birth weight; EN: enteral nutrition; G: group; GA: gestational age; F: oral infant formula; 
LBW: low birth weight; PN: parenteral nutrition; RG: reference group; SD: standard deviation; Se: selenium; VLBW: very low birth weight; Wk: week. 
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with selenium accumulation during gestation. This fact was 
observed in studies by Makhoul et al(8) and Galinier et al(30), who 
analyzed umbilical cord selenium concentration and noted a 
significant association with gestational age of newborn infants. 
Selenium concentration increased after 36 weeks in the former 
study and from the 26th to the 38th week in the latter study. 
Mentro, Smith and Moyer-Mileur(9) suggested that pre-
term infant’s small Se stores are used preferentially for GPx 
production, occurring in stable or increased GPx and decreased 
Se concentrations. This could explain the poor correlation 
between selenium and GPx concentrations observed in the 
studies(9,18,21,24,31). Another possibility is that the natural defenses 
antioxidant like enzyme GPx, mature along the gestation. So, 
in premature animal, the GPx probably are poorly developed(32).
According to Daniels, Gibson and Simmer(18) and Mentro, 
Smith and Moyer-Mileur(9), GPx concentrations might be 
Table 2 - Main results found in publications about the relationship between alterations in selenium status and age
Author Results 
Amin et al, 1980(28) The mean serum concentration in term infants (0.098±0.025μg/mL) was slightly higher 
than preterm infants (0.032 μg/ml), but there was not difference significant.
Lockitch et al, 1989(21) The mean concentration decreased from 0.74±0.13 to 0.63±0.15μmol/L at day 7 
(p=0.01) and at day 14 decreased to 0.51±0.19μmol/L (p<0.001). Se values decreased 
in all 16 preterm infants followed over the first 50 days. In 11 infants, levels dropped to 
<0.22μmol/L (17μ/L). 
Smith et al,1991(29) After 3th week there were no significant differences of Se concentration between groups 
(preterm infants with F and BF). 
Mask et al, 1993(27) The plasma Se was lower in preterm newborns (0.08±0.02μg/mL) than term newborns 
(0.10±0.02μg/ml), p=0.052. 
Darlow et al, 1995(32) There was no significant correlation between gestational period and plasma Se. The 
correlations among GPx and plasma Se was weak at birth (0.39) and at 28 days (0.17).
Merz et al, 1998(40) After birth the value of plasma Se was 34.2μg/L and reduced to 16.1μg/L after 4 weeks 
(p<0.001).
Klinger et al, 1999(39) No correlation was observed between the plasma Se and gestational age (r=0.27,  
p=0.16). There was significant correlation between gestational age and the level of T4  
(r=0.45; p=0.02).
Winterbourn et al, 2000(48) There was no statistically significant difference in GA between the group with and without Se. 
Sievers et al, 2001(45) Plasma Se concentrations in preterm newborns were 11.7 (6.5–20.8)μg/L (assessment in 
the hospital).  At 4 months: preterm newborns = 11.6 (8.8–16.7)μg/L, term newborns fed 
with IF=31.3 (24.3–47.5)μg/L and term newborns BF=45.6 (27.1–65.1)μg/L. 
Makhoul et al, 2004(8) Linear relationship between umbilical cord blood concentrations and GA (r =0.341, 
p<0.0001).
Mentro, Smith, 
 Moyer-Mileur, 2004(9)
Se concentrations decreased from the 1st to 4th wk of life. Plasma Se (SD)=0.97±0.21μmol/L 
in the 1st wk and 0.72±0.27 μmol/L in the 4th wk  (p=0.001). There was not change in plasma 
GPx among week 1 and 4. The erythrocyte GPx increased along the time period (t =-3.38; 
p=0.004) and was associated to the GA.
Galinier et al, 2005(30) Se concentration increased with GA from 0.4±0.1μmol/L (26th to 33rd week) to  
0.5±0.1μmol/L (from the 33rd to the 37th week) and 0.6±0.1μmol/L (>37th weeks) (p<0.001, 
r=0.593).
Nassi et al, 2009(10) Up until 20 days postnatal, the GPx was lower in the preterm infants than in the 
 term infants. 
BF: breastfed; GA: gestational age; GPx: glutathione peroxidase; Se: selenium. 
131
Rev Paul Pediatr 2014;32(1):126-35.
Renata Germano B. O. N. Freitas et al
confounded by supplemental oxygen and steroids which are 
common practice for preterm infants. Thus according to au-
thors, GPx activity may be a poor functional indicator of seleni-
um status in infants(10,31-33), especially in preterm infants(8,9,24,32). 
But GPx, seems to be a good marker for adults(8,18,32). 
Prematurity also affects birth weight(34). Birth weight is 
the anthropometric indicator that has the greatest influence 
on health and newborn survival(33,35-37). Makhoul et al(8) and 
Lockitch et al(21) observed that the lower the weight, the lower 
the concentration of selenium in newborns. Bogye, Alfthan 
and Machay(38) stated that very low birth weight premature 
infants are obviously susceptible to selenium deficiency. 
Selenium deficiency has also been associated with a greater 
number of diseases and clinical complications. Klinger 
et  al(39) found selenium deficiency in most premature infants 
however, there was not a significant correlation between 
selenium levels and thyroid hormones.
Merz et al(40) found no relationship between the incidence 
of bronchopulmonary dysplasia and selenium status. Darlow 
et al(24) suggested that low Se concentrations may be associ-
ated an increase in risk to lung injury.
Darlow et al(32) were the first to demonstrate in humans 
an association between low plasma selenium levels and a 
greater risk of lung disease, evidenced by oxygen require-
ment and dependency in the 28th day of life of the affected 
patients. Mentro, Smith and Moyer-Mileur(9) showed that, 
despite a reduction in selenium plasma levels, increased 
selenium ingestion was associated with a reduction in oxy-
gen dependency. In fact, selenium supplementation would 
act against oxidative stress caused by early exposure to 
an oxygen-rich environment, in addition to supplemental 
oxygen provided in some cases. 
Daniels, Gibson and Simmerb(18) found no significant 
difference in the incidence of retinopathy of prematurity 
Table 3 - Main results found in publications about alterations in selenium concentration and clinical status
Author/year Results
Darlow et al, 1995(32) Between 48h and 28 days of life, it was observed that each 0.1µmol/L decrease in 
plasma Se was associated with a 28% increase in the number of days the infants 
received O2 (95%CI -0.5–64; p= 0.06). In the 28th day, plasma Se was significantly 
lower in preterm newborns with CLD (p<0.001). Mean plasma Se was lower in preterm 
newborns with BPD.  And each 0.1 µmol/L decrease in plasma Se was associated with a 
58% increase in days of O2 dependency. 
Daniels et al, 1996(18) When boys were analyzed separately, it was noticed that the incidence of CLD is 
similar between groups (60% in BW without supplementation and 63% in BW with 
supplementation).
Merz et al, 1998(40) Se values were not significantly different among the preterm infants with and without BPD.
Klinger et al, 1999(39) 26 infants was diagnosed with Se deficiency (serum levels were <0.72µM). Low values  
of T4 were found in 10 of the 26 children who also had low levels of Se, but it was not 
observed low levels of TSH. No correlation was observed between the plasma Se and 
T4 (r=0.36; p=0.06) or TSH (r =0.06; p=0.76).
Darlow et al, 2000(24) Before randomization the mean plasma Se was 0.33 μmol/l in both groups. In 28 days it 
had increased to 0.56μmol/L in the supplemented infants, but had dropped to 0.29μmol/L 
in the infants without Se (p<0.0001). The lower plasma Se found before randomization 
was associated with increased respiratory morbidity. After the first week, the infants with 
lower supplementation had an episode of sepsis (p<0.038).  
Winterbourn et al, 2000(48) There was a weak negative correlation with GPx in the 36th week (correlation 
coefficient, -0.23, p=0.01). Regarding MDA, there was no correlation with plasma Se 
and GPx at any given moment. Therefore, Se supplementation did not influence the 
levels of these markers. 
Mentro et al, 2004(9) Se ingestion in the 1st week was associated with a reduction in O2 dependency 
 in the 28th day.
BPD: bronchopulmonary dysplasia; CLD: chronic lung disease; GPx: glutathione peroxidase; GA: gestational age; LBW: low birth weight; 
MDA: malone dialdehyde; O2: oxygen; PN: parenteral nutrition; Se: selenium. 
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and intraventricular hemorrhage, but observed a higher in-
cidence of sepsis among premature infants without selenium 
supplementation.
Thus, feeding newborns with an adequate amount of sele-
nium is important to restore and to maintain selenium liver 
stores(9), preventing a number of disorders and complications, 
as well as to support the appropriate growth and develop-
ment of newborn infants.
Daniels et al(31) suggest that supplementation should 
be at least equivalent to the amount of selenium in breast 
milk of women from the same geographical region; after 
all, there are some regions where soils are low in selenium, 
Table 4 - Main results found in publications about alterations in selenium concentrations and feeding provided
Author/year Results
Amin et al, 1980(28) Premature infants without Se supplemented had low Se levels the 2nd week (0.063μg/mL). 
But when the preterm infants were fed with formula (with Se), the concentrations increased 
to 0.079μg/mL the 4th-6th week of age.
Huston et al, 1991(47) Se concentrations dropped in infants with and without added Se when PN was 
discontinued, but were significantly higher in the preterm infants supplemented with EN. 
GPx demonstrated a significant increase in supplemented group with EN and then tended 
to fall. In preterm without Se, GPx tended to increase; then dropped significantly when PN 
was discontinued.
Smith et al, 1991(29) At the 3rd week, the plasma Se was greater in preterm infants BF than the preterm infants 
fed with F (p<0.05). There were no differences between groups for GPx concentrations.
Darlow et al, 1995(32) A reduction in plasma Se concentration was not significantly correlated with the 28th day of PN. 
Daniels et al, 1996(18) Along the 3 weeks, while all newborns received a mean 82% of daily energy by PN,  
Se plasma decreased in the PN group without Se  (p=0.001; n=17) and maintained the 
levels in PN with Se. Therefore, in infants without Se, plasma Se levels were significantly 
lower in the 3rd week (p=0.026). Se plasma concentration was ≤10μg/L and associated 
with deficiency symptoms in 24% of the PN group without Se and 13% in the PN group with  
Se. 3rd to 6th week: Among the RG, plasma Se increased in newborns BF  
(p=0.001; n=23) and decreased in newborns with F (p=0.039; n=8). Among preterm 
newborns, there was no significant change. 6th week: preterm newborns (with PN) and term  
newborns (with F) showed a reduction in Se plasma concentration compared to  
term newborns (with BF) (p<0.001).
The GPx activity increased in supplemented infants (p=0.042) and there was no change 
in unsupplemented infants (p=0.264).There was no difference in GPx among the groups 
at week 3 and 6.
Bogye et al, 1998(51) In the EN group without supplementation, mean serum Se concentration decreased 
significantly in 2 weeks from 34.4±20.4μg/L to 26.1±16.6μg/L (p<0.005). In the 
supplemented group, it increased from 36.1±12.8μg/L to 43.5±7.9μg/L (p<0.01).
Bogye et al, 1998(38) In the EN group without supplementation, the mean serum Se concentration decreased 
significantly in 2 weeks from 25.9±6.8 to 18.2±6.4μg/L (p<0.004). In the supplemented group, it 
increased significantly from 32.1±8.5 to 41.5±6.5μg/L (p<0.004).
Winterbourn et al, 2000(48) Supplementation resulted in a significant increase in plasma Se, virtually doubling 
the value compared to values observed before supplementation, with the major part 
increasing in the first week. Supplementation also prevented a decrease in GPx, already 
showing a statistically significant difference in the 1st week between groups.  
There was no significant difference in carbonyl protein concentrations and MDA between 
the supplemented group and the non-supplemented group.  
BF: breastfed; EN: enteral nutrition; F: oral infant formula; GPx: glutathione peroxidase; MDA: malone dialdehyde; PN: parenteral nutrition; 
RG: reference group; Se: selenium.
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as in New Zealand(32), Switzerland(41), China(42) and some 
states of Brazil(43).
Makhoul et al(8) stated that infants fed with maternal milk, 
regardless of being premature or not, do not require selenium 
supplementation. However, when feeding of these infants 
is based on infant formula, enteral or parenteral nutrition, 
supplementation is necessary even in term newborn infants. 
Most publications studied in this review showed an as-
sociation between feeding provided to infants — infant 
formulas administered by oral, enteral or parenteral route 
containing little or no addition of selenium — and low 
selenium concentrations(9,18,23,28,31,32,44). 
The current recommendations for selenium supple-
ments are based on the ingestion of selenium by infants 
fed with maternal milk, since it appears to meet newborn 
requirements(15,31,33). 
Currently, ASPEN (2012)(13) recommends 2μg/kg/day 
selenium in parenteral nutrition for the pediatric popula-
tion. There is no differentiation between preterm and term 
neonates, healthy and sick neonates, and between neonates 
with appropriate or low birth weight for gestational age.
Surveys claim that selenium concentrations are lower in 
preterm infants, especially in those with low birth weight 
(˂1,500 g) and very low birth weight (˂1,000g), when 
compared with term infants(22,37,38,45,46).
Daniels, Gibson and Simmer(18), studying preterm infants 
receiving parenteral nutrition, found selenium levels similar 
to those observed in children with Keshan disease. Huston, 
Jelen and Vidgoff(47) concluded that adding 1.34 µg/kg/day of 
selenium in PN is not adequate for LBW. Those authors ad-
ditionally suggested that supplementation with 3µg/kg/day 
of selenious acid was incapable of preventing significant 
decreases in plasma selenium concentration when compared 
with term newborn infants fed breast milk(18). This fact is 
concerning, since, according to the literature, supplementa-
tion may revert several clinical complications, although it 
is not efficient for reverting Keshan disease. 
Klinger et al(39) reported that supplementation of 
2µg/kg/day of selenium has not been able to prevent or 
reverse selenium deficiency. Thus, the authors support the 
recommendation to review premature infants guidelines. 
Makhoul et al(8) suggested that measurement of selenium 
levels recommended in parenteral nutrition should increase 
twofold (up to 7µg/kg/day). 
In a research conducted by Darlow(24), supplementa-
tion prevented the fall and achieved levels similar to those 
reported in term infants fed human milk. So, the authors 
suggest that VLBW infants should receive sufficient supple-
mentation to achieve levels observed in term infants fed 
human milk, despite the minimal benefits in the clinical 
picture found in research.
In a study by Winterbourn et al(48), supplementation 
(7µg/kg/day and 5µg/kg/day of sodium selenite in parenteral 
and oral nutrition, respectively) did not have an effect on 
oxidative stress, although selenium levels almost doubled 
and GPx showed a significant difference between groups with 
and without supplementation. This fact may be explained 
by the inadequate dose of selenium, the late supplementa-
tion, and also due to the scant evidence of oxidative stress 
among premature infants.
Despite the discussion about the optimal dose and length 
of selenium supplementation, several studies have shown 
that the addition of selenium may prevent diseases and their 
complications(6,17,49,51), including a shortened hospital stay 
and, consequently, lower financial costs.
Conclusion
Nutritional assessment of selenium status in the body to 
analyze biochemical indicators and clinical manifestations 
should be performed, especially in premature newborns 
who were not breastfed. Blood selenium concentrations 
are reduced in neonates, especially in those with lower 
gestational age and birth weight. Furthermore, newborn 
infants who are not breastfed and supplemented show the 
lowest selenium levels, including newborns, without any 
underlying disease. Therefore, supplementation is impor-
tant in preterm infants who were not breastfed in order to 
minimize the risks of diseases and complications associated 
with selenium deficiency, contributing to a healthy growth 
and development of the child.
The optimal dose and length of selenium supplementation 
have still not been well-established, since they are based only 
on age group and selenium ingestion in breastfed children. 
Furthermore, the clinical status of the infants affected by con-
ditions that may increase oxidative stress and, consequently, 
increase selenium requirements, was not taken into account. 
Thus, studies into this subject area are strictly necessary 
to encourage selenium supplementation in all countries and 
healthcare services, for the prevention or reversal of selenium 
deficiency and the resultant complications in humans, espe-
cially among newborn infants. 
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